4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-063372
Chief Financial Officer gave up 370 shares (to pay taxes)
- Chief Financial Officer acquired 1,300 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ruffo Frank Chief Financial Officer | 2018-12-15 | Option exercise | +1,300 | 161,885 | D | ||
| Ruffo Frank Chief Financial Officer | 2018-12-15 | Shares withheld for taxes | −370 | $7.31 | $2,705 | 161,515 | D |
| Derivatives | |||||||
| Ruffo Frank Chief Financial Officer | 2018-12-15 | Option exercise · Restricted Stock Units | −1,300 | 2,600 | D | ||
Loading xslF345X03/doc4.xml…